Compare Cytokinetics Inc (CYTK) vs iShares JPMorgan USD Emerging Markets Bond ETF (EMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs iShares JPMorgan USD Emerging Markets Bond ETF — how do they compare? Cytokinetics Inc trades at $82.49 (market cap $11.16B), while iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.75. The key difference: Cytokinetics Inc is trading nearer its 52-week high, iShares JPMorgan USD Emerging Markets Bond ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | EMB | |
|---|---|---|
Market Cap | $11.16B | — |
Sector | Technology | Fixed Income |
52-Week High | $87.26 | $97.74 |
52-Week Low | $33.23 | $91.52 |
Enterprise Value | $11.63B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →
